Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | 4C6H7O6.Mo |
| Molecular Weight | 796.4 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Mo+4].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]2OC(=O)C(O)=C2[O-].OC[C@H](O)[C@H]3OC(=O)C(O)=C3[O-].OC[C@H](O)[C@H]4OC(=O)C(O)=C4[O-]
InChI
InChIKey=GPNXNVXCMUMHTQ-ZZMUEVMSSA-J
InChI=1S/4C6H8O6.Mo/c4*7-1-2(8)5-3(9)4(10)6(11)12-5;/h4*2,5,7-10H,1H2;/q;;;;+4/p-4/t4*2-,5+;/m0000./s1
DescriptionSources: https://www.drugs.com/cons/ammonium-molybdate-intravenous-injection.html | https://www.ncbi.nlm.nih.gov/pubmed/27055119 | https://www.ncbi.nlm.nih.gov/pubmed/26435257 | https://www.ncbi.nlm.nih.gov/pubmed/10382558 | https://www.ncbi.nlm.nih.gov/pubmed/24470099 | https://www.cancercarewny.com/content.aspx?chunkiid=111707https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19711110&CC=GB&NR=1252799A&KC=A
Sources: https://www.drugs.com/cons/ammonium-molybdate-intravenous-injection.html | https://www.ncbi.nlm.nih.gov/pubmed/27055119 | https://www.ncbi.nlm.nih.gov/pubmed/26435257 | https://www.ncbi.nlm.nih.gov/pubmed/10382558 | https://www.ncbi.nlm.nih.gov/pubmed/24470099 | https://www.cancercarewny.com/content.aspx?chunkiid=111707https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19711110&CC=GB&NR=1252799A&KC=A
Molybdenum Hexachloride is an inorganic diamagnetic compound used for catalytic polymerization of cycloolefins.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Study of antitumor effect of selected vanadium and molybdenum organometallic complexes in human leukemic T-cells. | 2015-12-05 |
|
| The Co-induced Effects of Molybdenum and Cadmium on Antioxidants and Heat Shock Proteins in Duck Kidneys. | 2015-11 |
|
| Possible effects of metallosis on spermatozoal apoptotic genes expression in individuals with intramedullary nailing prosthesis. | 2014-06 |
|
| Multiple metals predict prolactin and thyrotropin (TSH) levels in men. | 2009-10 |
|
| Analysis of 35 inorganic elements in teeth in relation to caries formation. | 2009 |
|
| Functional characteristics of NaS2, a placenta-specific Na+-coupled transporter for sulfate and oxyanions of the micronutrients selenium and chromium. | 2005-01-25 |
|
| Molecular basis of proton motive force generation: structure of formate dehydrogenase-N. | 2002-03-08 |
|
| Effects of trace metal compounds on HIV-1 reverse transcriptase: an in vitro study. | 1999-05 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/ppa/molybdenum.html
Dietary Considerations
Dietary reference intake (IOM, 2011):
0 to 6 months: Adequate intake: 2 mcg daily
7 to 12 months: Adequate intake: 3 mcg daily
1 to 3 years: RDA: 17 mcg daily
4 to 8 years: RDA: 22 mcg daily
9 to 13 years: RDA: 34 mcg daily
≥14 to 18 years: RDA: 43 mcg daily
>18 years: RDA: 45 mcg daily
Pregnancy and lactation: RDA: 50 mcg daily
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
16142-78-2
Created by
admin on Wed Apr 02 12:08:50 GMT 2025 , Edited by admin on Wed Apr 02 12:08:50 GMT 2025
|
NON-SPECIFIC STOICHIOMETRY | |||
|
129719416
Created by
admin on Wed Apr 02 12:08:50 GMT 2025 , Edited by admin on Wed Apr 02 12:08:50 GMT 2025
|
PRIMARY | |||
|
3VRZ2B938L
Created by
admin on Wed Apr 02 12:08:50 GMT 2025 , Edited by admin on Wed Apr 02 12:08:50 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
ACTIVE MOIETY
SUBSTANCE RECORD